A Wheel of Health with Petra Majdič, healthy smooties and a funny hike
- Be Healthy Celebration Week is a central event of the Novartis Be Healthy initiative aimed at improving the health and well-being of employees.
- Lek, a Sandoz company, is organizing a Be Healthy Celebration Week for the fourth time in a row at all sites across Slovenia.
- This week, more than 3,000 employees are taking part in workshops and lectures on healthy living and different sports activities, learning about how to prepare healthy meals, refreshing their first aid knowledge and checking their vital signs.
More than 3,000 Novartis associates in Slovenia are participating this week in the Be Healthy Celebration Week, the central part of the global Novartis Be Healthy initiative. From September 8 to 12 the associates from all sites in Slovenia – in Ljubljana, Mengeš, Lendava and Prevalje – pay special attention to looking after their health and wellbeing. Once again they are encouraged by Petra Majdič.
The activities during the Be Healthy Celebration Week are designed so as to encompass all four pillars of the Be Healthy initiative (move, choose, know, manage) and therefore help to comprehensively address the health of employees. Through this week, the employees can participate in organized sports activities, lectures and training sessions for a healthier lifestyle during work hours. The topics are diverse and everyone can find something for himself/herself and designed so that they are informative and entertaining at the same time.
Once again, Petra Majdič, our Olympic medallist, joined the associates in Slovenia as a Healthy Living Ambassador, who with her immense energy always creates a good mood. This time she is spinning the Wheel of Health with us. »First year we were exercising, two years ago we were cooking, last year we learned nordic walking and this year we are spinning a Wheel of Health. The response from the employees is always good and I am happy to take part in this project because it brings results. People come, ask questions, participate, exchange experience, seek new ways to even better look after their health. The Be Healthy initiative and Be Healthy Celebration Week are excellent examples of how a company looks after the well-being of its employees« Petra Majdič pointed out.
Much attention is being paid to healthy eating and above all how to prepare food in a simple way. This time they are preparing, together with a renowned Slovenian expert, fresh smoothies and learn about the right combination of ingredients. Tomaž Vozelj, a renowned chef, is sharing healthy cooking tricks with them. They have healthy meals waiting for them in canteen, prepared in cooperation with a nutritionist.
The first aid courses are very well attended which proves that awareness of the importance of timely help when needed, is extremely high among associates of Lek, a Sandoz company. As a part of these courses, the use of automated defibrillators is being taught. On all four Sandoz locations across Slovenia there are 8 such defibrillators.
When caring for health it is very important to know your body, therefore free measurements of key numbers are available for the employees throughout this week. A doctor is measuring their body mass index, cholesterol, blood pressure and blood sugar and intra-ocular pressure.
As every year, the Be Healthy Celebration Week will be concluded with a hike. This year it will be additionally spiced up by famous Slovenian stand-up comedians who are coming along to join in. The employees from Ljubljana and Mengeš will be accompanied by Petra Majdič and Miha Brajnik. Martina Ipša will entertain the employees at the Lendava site and Matjaž Javšnik will encourage the employees from the Prevalje site.
About the Novartis global Be Healthy initiative
Caring for the health and quality of life of its employees is one of the key Novartis policies and a natural extension of the company purpose “caring and curing”. To that end, Novartis launched four years ago the internal initiative Be Healthy with which it wants to encourage the employees to take an active role in managing their own health. The global Be Healthy initiative is dedicated to all Novartis affiliates’ employees and it is being implemented throughout the whole year.
In Be Healthy, Novartis focuses on preventative programs as statistical data from the World Economic Forum (WEF) show that workplace health and well-being programs addressing lifestyle changes can help prevent up to 40% of non-communicable diseases (NCDs) such as cardiovascular disease, cancer and lung disorders. The World Health Organization recently announced a new target to reduce NCDs worldwide by 25% by 2025. The Be Healthy initiative is Novartis’ contribution towards this objective.
Be Healthy has a broad reach within Novartis. When it was launched in 2011, 76 of the largest Novartis sites across 32 countries were involved in the program reaching 80% of affiliates’ associates. This year, the initiative is being carried out in more than 176 sites in more than 50 countries across the world, 95% of employees are included in the program.
Lek, a Sandoz company, is one of key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/en.
Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in the generic pharmaceutical sector. Sandoz employs over 26,500 employees and its products are available in more than 160 countries, offering a broad range of high-quality, affordable products that are no longer protected by patents. With USD 9.2 billion in sales in 2013, Sandoz has a portfolio of approximately 1,100 molecules, and holds the #1 position globally in biosimilars as well as in generic injectables, ophthalmics, dermatology and antibiotics, complemented by leading positions in the cardiovascular, metabolism, central nervous system, pain, gastrointestinal, respiratory, and hormonal therapeutic areas. Sandoz develops, produces, and markets these medicines, as well as active pharmaceutical and biotechnological substances. Nearly half of Sandoz’s portfolio is in differentiated products, which are defined as products that are more difficult to scientifically develop and manufacture than standard generics.
In addition to strong organic growth since consolidating its generics businesses under the Sandoz brand name in 2003, Sandoz has benefitted from strong growth of its acquisitions, which include Lek (Slovenia), Sabex (Canada), Hexal (Germany), Eon Labs (US), EBEWE Pharma (Austria), Oriel Therapeutics (US), and Fougera Pharmaceuticals (US).
Sandoz is on Twitter. Sign up to follow @Sandoz_global at http://twitter.com/Sandoz_Global.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 135,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32